Sequencing Reagents Market size was valued at USD 7.93 billion in 2024 and is likely to reach USD 59.71 billion by the end of 2037, expanding at around 16.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of sequencing reagents is assessed at USD 9 billion.
The quick development in sequencing technology will primarily propel the market of market by the end of 2036. Illumina sequencing creation, sequencing by blend (SBS), may be an extensively approved next-generation sequencing (NGS) creation across the globe. Illumina sequencing instruments and reagents back considerably parallel sequencing utilizing an exclusive plan that acknowledges single bases as they are connected into growing DNA strands.
Another reason behind the massive growth of the sequencing reagents market is the limited costs of genetic sequencing. The HGP included beginning with mapping and after that sequencing the human genome. The previous was required at the time since there was something else no 'framework' for organizing the real sequencing or the coming about arrangement information. The maps of the human genome served as 'scaffolds' on which to put through personal portions of amassed DNA grouping. These genome-mapping endeavors were very costly but were basic at the time for producing an exact genome arrangement. It is troublesome to appraise the costs related to the 'human genome mapping phase' of the HGP, but it was certainly within the numerous tens of millions of dollars. The evaluation has taken a toll on creating that beginning 'draft' human genome arrangement is approximately USD 300 million around the world, of which NIH generally has 50-60%.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?